there would be no HYPERBARIC chambers ... there would be no OXYMED chambers ... our company would not exist ... if not for the Polish alchemist and doctor Michał Sędziwój. There are many indications that he was the discovering this element experimentally in 1604.

The origins of hyperbaric therapy date back to 1662, when the British physician and clergyman Nathaniel Henshaw constructed a prototype of a hyperbaric chamber - "domicilium" and used it to treat lung diseases in conditions of increased and reduced pressure.

At the end of the 18th century, treatment with oxygen was first described in France, which in the next 50 years became an extremely popular therapeutic method in this country for many diseases and conditions. It was found that in the course of oxygen therapy, blood flow to internal organs increases and blood supply to the brain improves. In the nineteenth century, hyperbaric therapy gained immense popularity all over Europe and was considered as a treatment on par with other treatments.

At the same time, hyperbaric medicine developed on the American continent, where it was initially used to treat "nerves and related disorders". The hyperbaric chamber built in the 1920s by Dr. Orville J. Cunningham of Kansas University gained enormous publicity. He was the first to use an oxygen chamber to heal victims of the Spanish flu, which the United States struggled with at the end of World War I. The scientific community recognized that oxygen therapy saved many patients from the then-fatal consequences of this disease. The undeniable success of Dr. Cunningham was the use of oxygen therapy to awaken millionaire Henry Timkin from a coma.

The latter, in gratitude, financed the doctor's crazy idea: the construction of a huge hyperbaric chamber - a spherical, steel building with a height of five floors and a diameter of 20 meters, in which patients with diabetes, hypertension, cancer and mental diseases were treated. It was one of the largest hyperbaric chamber in the history of hyperbaric medicine and has remained one of the largest to this day.

The foundations of modern hyperbaric therapy were developed based on early research and applications that highlighted the benefits of high-pressure oxygen environments. Notably, in 1955, the positive effects of high-pressure oxygen were recognized in various contexts, including recovery processes. Around the same time, innovative uses for pressurized oxygen environments were explored in procedures to extend their duration, demonstrating the versatility of hyperbaric conditions. This led to the construction of hyperbaric chambers worldwide for a variety of applications. In 1975, the convention of the first organization to explore the potential of hyperbaric environments - the Undersea Medical Society (UMS) in San Francisco - marked a significant milestone in the field, culminating in the publication of the first comprehensive guide on the subject. UMS also defined strict indications for the use of hyperbaric oxygen therapy (HBOT). In the following years, there was a rapid development of experimental and clinical research aimed at developing scientific foundations and confirming the effectiveness of hyperbaric oxygen therapy in the treatment of a number of diseases. These studies unequivocally confirmed the spectacularly positive effect of using HBOT therapy in the treatment of dozens of diseases and trauma. Oxygen therapy centers began to appear all over the world and hyperbaric medicine has become a very important and valued part of treatment. In 1994, the first European Consensus Congress on Hyperbaric Medicine was held, during which a list of indications for the use of hyperbaric oxygen therapy was established (consistent with the UMS findings from 1975) as well as the standards for staff training and equipment for hyperbaric oxygen therapy (HBOT) centers.

Hyperbaric Chamber Ireland
Hyperbaric Chamber Ireland
Hyperbaric Chamber Ireland